Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÜnüvar, Tolga
dc.contributor.authorBüyükgebiz, Atilla
dc.date.accessioned2015-10-01T07:02:48Z
dc.date.available2015-10-01T07:02:48Z
dc.date.issued2012
dc.identifier.citationUnüvar T, Büyükgebiz A. Fetal and neonatal endocrine disruptors. J Clin Res Pediatr Endocrinol. 2012; 4(2): 51-60. doi: 10.4274/jcrpe.569.en_US
dc.identifier.issn1308-5727
dc.identifier.urihttp://www.jcrpe.org/archive/en_US
dc.identifier.urihttps://hdl.handle.net/11446/800en_US
dc.descriptionİstanbul Bilim Üniversitesi, Tıp Fakültesi.en_US
dc.description.abstractEndocrine disruptors are substances commonly encountered in every setting and condition in the modern world. It is virtually impossible to avoid the contact with these chemical compounds in our daily life. Molecules defined as endocrine disruptors constitute an extremely heterogeneous group and include synthetic chemicals used as industrial solvents/lubricants and their by-products. Natural chemicals found in human and animal food (phytoestrogens) also act as endocrine disruptors. Different from adults, children are not exposed only to chemical toxins in the environment but may also be exposed during their intrauterine life. Hundreds of toxic substances, which include neuro-immune and endocrine toxic chemical components that may influence the critical steps of hormonal, neurological and immunological development, may affect the fetus via the placental cord and these substances may be excreted in the meconium. Children and especially newborns are more sensitive to environmental toxins compared to adults. Metabolic pathways are immature, especially in the first months of life. The ability of the newborn to metabolize, detoxify and eliminate many toxins is different from that of the adults. Although exposures occur during fetal or neonatal period, their effects may sometimes be observed in later years. Further studies are needed to clarify the effects of these substances on the endocrine system and to provide evidence for preventive measures.en_US
dc.description.sponsorshipTurkish Pediatric Endocrinology and Diabetes Societyen_US
dc.language.isoengen_US
dc.publisherGalenos Yayınevien_US
dc.identifier.doi10.4274/jcrpe.569en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectendocrine disruptorsen_US
dc.subjectfetalen_US
dc.subjectneonatalen_US
dc.titleFetal and neonatal endocrine disruptors.en_US
dc.typearticleen_US
dc.relation.journalJournal of clinical research in pediatric endocrinologyen_US
dc.departmentDBÜ, Tıp Fakültesien_US
dc.identifier.issue2
dc.identifier.volume4
dc.identifier.startpage51
dc.identifier.endpage60
dc.contributor.authorIDTR184089en_US
dc.contributor.authorIDTR143788en_US
dc.relation.publicationcategoryBelirsizen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster